Clinical Trial Update: Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing irinotecan plus S-1 versus S-1 alone in previously treated advanced esophageal cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Irinotecan (Camptosar) (Irinotecan)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Esophageal Neoplasms | Phase 3 | Status: UNKNOWN